Haloperidol and Erythema multiforme - a phase IV clinical study of FDA data

Summary:

Erythema multiforme is reported as a side effect among people who take Haloperidol (haloperidol), especially for people who are female, 60+ old, have been taking the drug for < 1 month also take Furosemide, and have High blood pressure.

The phase IV clinical study analyzes which people have Erythema multiforme when taking Haloperidol. It is created by eHealthMe based on reports of 16,432 people who have side effects when taking Haloperidol from the FDA, and is updated regularly.

What is Haloperidol?

Haloperidol has active ingredients of haloperidol. It is often used in schizophrenia. eHealthMe is studying from 16,637 Haloperidol users. Check the latest studies of Haloperidol.

What is Erythema multiforme?

Erythema multiforme (a type of hypersensitivity reaction) is found to be associated with 1,707 drugs and 2,920 conditions by eHealthMe. Check the latest studies of Erythema multiforme.

On Apr, 18, 2026

16,432 people reported to have side effects when taking Haloperidol.
Among them, 150 people (0.91%) have Erythema multiforme.

Could Haloperidol cause Erythema multiforme?

Among these 150 people:

How long have people been on Haloperidol when they have Erythema multiforme? *

Click here to view more results

What is the gender of people who have Erythema multiforme when taking Haloperidol? *

Click here to view

What is the age of people who have Erythema multiforme when taking Haloperidol? *

Click here to view more results

* Approximation only. Some reports may have incomplete information.

Do you take Haloperidol and have Erythema multiforme?

- Check whether Erythema multiforme is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Haloperidol:

Haloperidol (16,637 reports)

Erythema multiforme treatments and more:

Erythema multiforme (56,072 reports)

How severe was Erythema multiforme and when was it recovered:

Erythema multiforme in Haloperidol

Expand to all the drugs that have ingredients of haloperidol:

Erythema multiforme and drugs with ingredients of haloperidol (334 reports)

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Haloperidol:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Erythema multiforme:

Erythema multiforme (1,707 drugs)

Browse all the conditions that are associated with Erythema multiforme:

Erythema multiforme (2,920 conditions)

Related publications that referenced our studies

Obayi, O., & Tagbo, N. , "Bilateral Pedal Oedema Associated with Intramuscular Haloperidol–A Rare Observation", International Neuropsychiatric Disease Journal, 2018 Jan .
Tognetti L, Giorgini S, Lotti T, "Erythema multiforme-like eruption from a slimming drug preparation cutaneous adverse drug reaction", Indian dermatology online journal, 2011 Jan .
Obayi, O., & Tagbo, N. , "Bilateral Pedal Oedema Associated with Intramuscular Haloperidol–A Rare Observation", International Neuropsychiatric Disease Journal, 2018 Jan .
Tognetti L, Giorgini S, Lotti T, "Erythema multiforme-like eruption from a slimming drug preparation cutaneous adverse drug reaction", Indian dermatology online journal, 2011 Jan .

How the study uses the data?

The study uses data from the FDA. It is based on haloperidol (the active ingredients of Haloperidol) and Haloperidol (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.